WHO, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation, 4ā5 April 2001. WHO/CDS/ RBM/2001.35. Geneva: World Health Organization.
Baker L, Barnes K, 2001. New antimalarial treatment for KwaZulu Natal. S Afr Med J 91 :358ā359.
White NJ, 1998. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates 1 :3ā9.
Bloland PB, Ettling M, Meek S, 2000. Combination therapy for malaria in Africa: Hype or hope? Bulletin of the World Health Organization 78 :1378ā1388.
Ettling MB, 2002. The control of Malaria in Viet Nam from 1980 to 2000: What went right? Report of Consultancy for World Health Organization Regional Office for the Western Pacific, Manila.
Nosten F, Hien TT, White NJ, 1998. Use of artemisinin derivatives for the control of malaria. MeĢdecine Tropicale 58 (suppl 3) :45ā49.
Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68 :127ā132.
Kapp C, 2002. Global Fund faces uncertain future as cash runs low. Lancet 360 :1225.
Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR, 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359 :1365ā1372.
Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxineāpyrimethamine, amodiaquine and the sulfadoxineāpyrimethamineāamodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80 :538ā545.
Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ, 2002. Sulfadoxine/ pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360 :2031ā2038.
Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, 2001. Amodiaquine, sulfadoxine/ pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358 :368ā374.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 16 | 16 | 5 |
Full Text Views | 195 | 73 | 1 |
PDF Downloads | 32 | 13 | 0 |
WHO, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation, 4ā5 April 2001. WHO/CDS/ RBM/2001.35. Geneva: World Health Organization.
Baker L, Barnes K, 2001. New antimalarial treatment for KwaZulu Natal. S Afr Med J 91 :358ā359.
White NJ, 1998. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates 1 :3ā9.
Bloland PB, Ettling M, Meek S, 2000. Combination therapy for malaria in Africa: Hype or hope? Bulletin of the World Health Organization 78 :1378ā1388.
Ettling MB, 2002. The control of Malaria in Viet Nam from 1980 to 2000: What went right? Report of Consultancy for World Health Organization Regional Office for the Western Pacific, Manila.
Nosten F, Hien TT, White NJ, 1998. Use of artemisinin derivatives for the control of malaria. MeĢdecine Tropicale 58 (suppl 3) :45ā49.
Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamya MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68 :127ā132.
Kapp C, 2002. Global Fund faces uncertain future as cash runs low. Lancet 360 :1225.
Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR, 2002. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359 :1365ā1372.
Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxineāpyrimethamine, amodiaquine and the sulfadoxineāpyrimethamineāamodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80 :538ā545.
Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ, 2002. Sulfadoxine/ pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360 :2031ā2038.
Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, 2001. Amodiaquine, sulfadoxine/ pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358 :368ā374.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 16 | 16 | 5 |
Full Text Views | 195 | 73 | 1 |
PDF Downloads | 32 | 13 | 0 |